Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study

Critical Care Medicine

Volumn 33, Issue 9, 2005, Pages 1897-1902

  Albanèse, Jacques ^a   Leone, Marc ^a   Delmas, Anne ^a   Martin, Claude ^a  

^a HÔPITAL NORD   (France)

Author keywords

Catecholamines; Norepinephrine; Septic shock; Terlipressin

Indexed keywords

CREATININE; METICILLIN; NORADRENALIN; OXYGEN; TERLIPRESSIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FLUID THERAPY; HEART INDEX; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; HUMAN; INTENSIVE CARE; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; OPEN STUDY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; STROKE; VASCULAR RESISTANCE;

EID: 24944589992     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000178182.37639.D6     Document Type: Article

References (33)

1. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 23:588-595
2. Ince C, Sinaasappel M: Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999; 27:1369-1377
3. Vincent JL: Hemodynamic support in septic shock. Intensive Care Med 2001; 27:80-92
4. Ronco JJ, Fenwick JC, Tweeddale MG, et al: Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 1993; 270:1724-1730
5. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
6. Desjars P, Finaud M, Potel G, et al: A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15:134-137
7. Reinhart K, Sakka SG, Meier-Hellmann A: Haemodynamic management of a patient with septic shock. Eur J Anaesthesiol 2000; 17:6-17
8. Schreuder WO, Schneider AJ, Groeneveld AB, et al: Effect of dopamine versus norepinephrine on hemodynamic in septic shock: Emphasis on right ventricular performance. Chest 1989; 95:1282-1288
9. Bonzon L, Rosendorff C, Scriven DR, et al: The effect of noradrenaline, adrenergic blocking agents, and tyramine on the intrarenal distribution of blood flow in the baboon. Cardiovasc Res 1975; 9:314-322
10. Chand N, Altura BM: Reactivity and contractility of rat main pulmonary artery to vasoactive agents. J Appl Physiol 1980; 49:1016-1021
11. Takakura K, Taniguchi T, Muramatsu I, et al: Modification of alph1-adrenoreceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit Care Med 2002; 30:894-899
12. Landry DW, Levin HR, Gallant EM, et al: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279-1282
13. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on haemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-1421
14. Dünser M, Luckner G, Mayr A, et al: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis. Anesth Analg 2001; 93:7-13
15. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
16. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine resistant septic shock. Lancet 2002; 359:1209-1210
17. Morelli A, Rocco M, Conti G, et al: Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 2004; 30:597-604
18. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1658-1662
19. Martin C, Viviand X, Leone M, et al: Effect of norepinephrine on the outcome of septic shock. Crit Care med 2000; 28:2758-2765
20. Westphal M, Stubbe H, Sielenkämper AW, et al: Terlipressin dose response in healthy and endotoxemic sheep: Impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003; 29:301-308
21. Montani JP, Liard JF, Schoun J, et al: Memodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res 1980; 47:346-355
22. Undesser KP, Hasser EM, Haywood JR, et al: Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits. Circ Res 1985; 56:410-417
23. Klinzing S, Simon M, Reinhart K, et al: High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2004; 31:2646-2650
24. Dünser MW, Mayr AJ, Ulmer H, et al: Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 2003; 107:2313-2379
25. Bellomo R, Di Giantomaso D: Noradrenaline and the kidney: Friends or foes ? Crit Care 2001; 5:294-298
26. Hesselvik JF, Brodin B: Low-dose norepinephrine in patients with septic shock and oliguria: Effects on afterload urine flow, and oxygen transport. Crit Care Med 1989; 17:179-180
27. Meadows D, Edwards JD, Wilkins RG, et al: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-666
28. Martin C, Eon B, Saux P, et al: Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18:282-285
29. Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1990; 18:1048-1049
30. Redl-Wenzel EM, Armbruster C, Edelmann G, et al: The effects of norepinephrine on haemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19:151-154
31. Bellomo R, Kellum JA, Winiewski SR, et al: Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999; 159:1186-1192
32. Zhang H, Smail N, Cabral A, et al: Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxemic shock. Am J Respir Crit Care Med 1997; 1555:1965-1971
33. Edwards RM, Trizna W, Kinter LB: Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 1989; 256:F274-278